NCT01466894View on ClinicalTrials.gov

Safety and Efficacy Study of IMM 124-E (Bovine Colostrum) for Patients With Nonalcoholic Steatohepatitis

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Nonalcoholic Steatohepatitis
Interventions
BIOLOGICAL

IMM 124-E

Tablets orally twice a day for 24 weeks

BIOLOGICAL

Placebo

Tablets orally twice daily for 24 weeks

Sponsors

Lead Sponsor

Immuron Ltd.
All Listed Sponsors
lead

Immuron Ltd.

INDUSTRY

NCT01466894 - Safety and Efficacy Study of IMM 124-E (Bovine Colostrum) for Patients With Nonalcoholic Steatohepatitis | Biotech Hunter | Biotech Hunter